disulfide-stabilized single-chain variable region fragment of the anti-EGFR wild type/EGFRvIII dual specificity monoclonal antibody with variable fragments fused to a truncated version of the Pseudomonas exotoxin A, PE38, and KDEL

	disulfide-stabilized single-chain variable region fragment of the anti-EGFR wild type/EGFRvIII dual specificity monoclonal antibody with variable fragments fused to a truncated version of the Pseudomonas exotoxin A, PE38, and KDEL
Trade Name
Orphan Indication	Glioma
USA Market Approval	USA
USA Designation Date	2016-09-19 00:00:00
Sponsor	Darell D. Bigner, MD, PhD;Duke University Medical Center, Oreuss Laboratory -Brain Tumor Research;Durham, North Carolina, 27710

Related Access Program

Center Trials & Treatment – Glioma of Brain Oncoceutics, Inc. – Glioma